EFFECTS OF TOPICAL ETHACRYNIC-ACID OINTMENT VS TIMOLOL ON INTRAOCULAR-PRESSURE IN GLAUCOMATOUS MONKEY EYES

Citation
Rf. Wang et al., EFFECTS OF TOPICAL ETHACRYNIC-ACID OINTMENT VS TIMOLOL ON INTRAOCULAR-PRESSURE IN GLAUCOMATOUS MONKEY EYES, Archives of ophthalmology, 112(3), 1994, pp. 390-394
Citations number
10
Categorie Soggetti
Ophthalmology
Journal title
ISSN journal
00039950
Volume
112
Issue
3
Year of publication
1994
Pages
390 - 394
Database
ISI
SICI code
0003-9950(1994)112:3<390:EOTEOV>2.0.ZU;2-0
Abstract
Objective: To evaluate the long-term effects of ethacrynic acid (ECA) ointment, compared with timolol maleate on intraocular pressure (IOP) in cynomolgus monkey eyes with argon laser-induced glaucoma. Methods: In a 5-day study, IOP was measured for 7 hours after once-daily topica l applications of ECA ointment to four glaucomatous monkey eyes. For t his study, ECA ointment was given in 0.5%, 1.0%, 1.5%, or 2.5% concent rations. In a separate 30-day study, IOP was measure after once-daily topical applications of ECA ointment in concentrations of 0.75% or 1.5 %. The results were compared with IOP after the application of 0.5% ti molol maleate administered twice daily on weekdays and once daily on w eekends. Results: In the 5-day study, 2.5% ECA ointment had the greate st effect on lowering IOP, with a maximum reduction of 8.5+/-2.9 mm Hg (mean+/-SEM). A more pronounced reduction in IOP was observed on the fifth day of treatment for each of the four concentrations. In the 30- day study, 1.5% ECA ointment or 0.5% timolol maleate reduced IOP as mu ch as 11.5+/-3.7 mm Hg and 14.0+/-4.5 mm Hg, respectively. With repeti tive dosing, the effect on IOP after using 1.5% ECA ointment increased with time. Mild eyelid edema, conjunctival hyperemia, and discharge w ere observed in some eyes treated with the highest concentrations. One eye of four treated with 1.5% ECA ointment for 30 days developed a su perficial corneal erosion in the 30-day study. Conclusions: The ECA oi ntment reduced IOP in glaucomatous monkey eyes. This reduction was evi dent by the fifth day of treatment with all the concentrations tested. The reduction in IOP produced by once-daily treatment with 1.5% ECA o intment was comparable with that of 0.5% timolol maleate administered twice daily. Therefore, drugs in this class of compound may prove to b e useful in glaucoma therapy.